- Home
- TSHA vs NAK Comparison
TSHA vs NAK Comparison
Compare TSHA & NAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TSHA
- NAK
- Stock Information
- Founded
- TSHA 2019
- NAK 1983
- Country
- TSHA United States
- NAK Canada
- Employees
- TSHA N/A
- NAK N/A
- Industry
- TSHA Biotechnology: Pharmaceutical Preparations
- NAK Precious Metals
- Sector
- TSHA Health Care
- NAK Basic Materials
- Exchange
- TSHA Nasdaq
- NAK Nasdaq
- Market Cap
- TSHA 728.4M
- NAK 689.4M
- IPO Year
- TSHA 2020
- NAK 2002
- Fundamental
- Price
- TSHA $2.46
- NAK $1.35
- Analyst Decision
- TSHA Strong Buy
- NAK Strong Buy
- Analyst Count
- TSHA 7
- NAK 1
- Target Price
- TSHA $7.57
- NAK $1.30
- AVG Volume (30 Days)
- TSHA 5.2M
- NAK 7.7M
- Earning Date
- TSHA 08-11-2025
- NAK 08-14-2025
- Dividend Yield
- TSHA N/A
- NAK N/A
- EPS Growth
- TSHA N/A
- NAK N/A
- EPS
- TSHA N/A
- NAK N/A
- Revenue
- TSHA $7,224,000.00
- NAK N/A
- Revenue This Year
- TSHA N/A
- NAK N/A
- Revenue Next Year
- TSHA N/A
- NAK N/A
- P/E Ratio
- TSHA N/A
- NAK N/A
- Revenue Growth
- TSHA N/A
- NAK N/A
- 52 Week Low
- TSHA $1.05
- NAK $0.27
- 52 Week High
- TSHA $3.31
- NAK $1.43
- Technical
- Relative Strength Index (RSI)
- TSHA 45.90
- NAK 63.31
- Support Level
- TSHA $2.48
- NAK $1.15
- Resistance Level
- TSHA $2.66
- NAK $1.43
- Average True Range (ATR)
- TSHA 0.21
- NAK 0.10
- MACD
- TSHA -0.06
- NAK 0.01
- Stochastic Oscillator
- TSHA 10.14
- NAK 76.39
About TSHA Taysha Gene Therapies Inc.
Taysha Gene Therapies Inc is a patient-centric gene therapy company to eradicate monogenic CNS disease. It is focused on developing and commercializing AAV-based gene therapies for the treatment of monogenic diseases of the CNS in both rare and large patient populations. The company develops and commercializes transformative gene therapy treatments. Its product pipeline includes, TSHA-102 which is a is a self-complementary intrathecally delivered AAV9 gene transfer therapy in clinical evaluation for Rett syndrome.
About NAK Northern Dynasty Minerals Ltd.
Northern Dynasty Minerals Ltd is a mineral exploration company. It has a single operating segment of acquisition, exploration, and development of mineral properties. Its core asset is the Pebble Project located in Alaska, USA. The Pebble project is seeking to develop a deposit of copper, gold, molybdenum, and silver into a modern mining operation.